The Readout Loud
409 episodes — Page 9 of 9
Episode #8 - Megamergers, migraines, and biotech's Four Horsemen
What's a good use of $64 billion? Is Big Biotech boring now? And what's the best way to sell hair restoration products to men?
Episode #7 - Coke and Pepsi of lung cancer, a debatable drug price, and a cure for capitalism
Is Bristol-Myers Squibb into self-sabotage? Is Congress coming for Gut Guy? And why does Goldman Sachs love money so much?
Episode #6 - Biotech buyouts, CEO breakups, and The Rock does CRISPR
Why are biotech investors suddenly so exuberant? What does it mean when a CEO scrubs his LinkedIn profile? And can CRISPR turn your dog into a winged hellhound bent on destroying Chicago?
Episode #5 - The FDA's cold shoulder, the latest CAR-T contender, and BuzzFeed's scoop on Grindr
What's it like to be a biotech investor? Do you know where your genetic data are? And what does it mean when the FDA swipes left on your drug?
Episode #4 - Mr. Drug CEO doesn't go to DC, billionaires fighting drug prices, a biotech report card
Why aren't pharma CEOs getting hauled into Congress? Which biotech companies got a failing grade this quarter? And why is there no Kelley Blue Book for the price tag of a medicine?
Episode #3 - A gene therapy story, breaking down Incyte’s future, and was Gottlieb wrong to try?
What’s it like to watch gene therapy happen? Is the next big cancer clinical trial going to work? And is “right to try” going to defang the FDA?
Episode #2 - Theranos’s fate, biotech’s awkward SXSW, and a word on cow loogies
Did Elizabeth Holmes get off easy? Why does biotech bother with SXSW? And what does shoving a tube into a dead cow’s throat have to do with biotech?
Episode #1 - Shkreli's sentence, biotech froth, and a blood party
How long is Martin Shkreli going to be in prison? Is the biotech bubble about to burst? And what's it like to attend a blood-swapping gala? Listen to our first episode of, "The Readout LOUD."
Coming soon: "The Readout LOUD"
An introduction to a new weekly biotech podcast from STAT.